Susquehanna International Group, LLP Liquidia Corp Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 15, 2024	SELL	$11.96 - $15.71 $2.72 Million - $3.57 Million	-227,400 Reduced 50.01%	227,300 $2.73 Million
Q1 2024 May 07, 2024	SELL	$11.35 - $16.73 $1.15 Million - $1.69 Million	-101,100 Reduced 18.19%	454,700 $6.71 Million
Q4 2023 Feb 14, 2024	BUY	$5.77 - $12.19 $2.08 Million - $4.39 Million	360,200 Added 184.15%	555,800 $6.69 Million
Q3 2023 Nov 14, 2023	BUY	$6.27 - $8.15 $302,841 - $393,645	48,300 Added 32.79%	195,600 $1.24 Million
Q2 2023 Aug 11, 2023	BUY	$6.63 - $9.9 $684,879 - $1.02 Million	103,300 Added 234.77%	147,300 $1.16 Million
Q1 2023 May 16, 2023	SELL	$5.72 - $7.91 $49,764 - $68,817	-8,700 Reduced 16.51%	44,000 $304,000
Q4 2022 Feb 14, 2023	SELL	$4.68 - $6.54 $1.21 Million - $1.68 Million	-257,500 Reduced 83.01%	52,700 $335,000
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $1.1 Million - $2.48 Million	295,800 Added 2054.17%	310,200 $1.69 Million

157

35.9M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $658M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.